Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) EV to CFO (2023 - 2026)

Updated

Alnylam Pharmaceuticals' (ALNY) EV to CFO came in at 40.52 for Q2 2026, down 29.6% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) EV to CFO (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to CFO at Alnylam Pharmaceuticals was 31.05; for FY2025, it was 94.89.

  • In prior years, Alnylam Pharmaceuticals' EV to CFO was 207.86 in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly EV to CFO in data going back to Q3 2023.
  • According to Business Quant data, EV to CFO for the three prior quarters was 57.55 (Q1 2026), 94.89 (Q4 2025) and 215.80 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.52
Mar 31, 2026 57.55
Dec 31, 2025 94.89
Sep 30, 2025 215.80
Sep 30, 2024 577.55
Jun 30, 2024 76.54
Mar 31, 2024 87.46
Dec 31, 2023 207.86
Sep 30, 2023 10,046.65
API Access

Alnylam Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ALNY&period=max&api_key=YOUR_API_KEY